• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Gastric Bypass Market

    ID: MRFR/MED/15158-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US Gastric Bypass Market Research Report By Type (Endoscopic Sleeve Gastroplasty, Intragastric Balloon), By Indication (Gastroesophageal Reflux Disease, Heart Disease, Type 2 Diabetes) and By End User (Hospitals, Surgical Centers) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Gastric Bypass Market Infographic
    Purchase Options

    US Gastric Bypass Market Summary

    The US Gastric Bypass market is projected to grow significantly from 250 USD Million in 2024 to 550 USD Million by 2035.

    Key Market Trends & Highlights

    US Gastric Bypass Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 7.43% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 550 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 250 USD Million, reflecting the current demand for gastric bypass procedures.
    • Growing adoption of gastric bypass surgeries due to increasing obesity rates is a major market driver.

    Market Size & Forecast

    2024 Market Size 250 (USD Million)
    2035 Market Size 550 (USD Million)
    CAGR (2025-2035) 7.43%

    Major Players

    Hologic, Bariatric Solutions, Medtronic, Boston Scientific, Acelity, Conmed, Stryker, Cook Medical, Terumo, Hernia Solutions, Zimmer Biomet, Johnson and Johnson, Ethicon, Reach Surgical, Intuitive Surgical

    US Gastric Bypass Market Trends

    The US Gastric Bypass Market is experiencing several significant trends shaped by various factors. A primary market driver is the rising prevalence of obesity among the American population, which has led to increased demand for bariatric surgeries as an effective treatment option.

    Government health initiatives aimed at reducing obesity-related health problems have also promoted awareness about the benefits of surgical interventions. Additionally, technological advancements in surgical procedures, including minimally invasive techniques, have gained traction, making gastric bypass surgeries safer and more effective; this has resonated well with patients and healthcare providers alike.

    There are notable opportunities to be explored within the market. Increased insurance coverage for bariatric procedures, spurred by changes in policy related to obesity management, allows more individuals to consider gastric bypass as a viable option. Furthermore, the development of innovative preoperative and postoperative care programs offers potential for improving patient outcomes, thereby appealing to both healthcare providers and patients looking for comprehensive treatment solutions.

    In recent times, trends in the US include a shift towards more personalized treatment plans that cater to the specific needs and health status of patients, reflecting broader movements in healthcare towards tailored treatments. The integration of digital health tools, such as telemedicine and mobile health applications, is enhancing patient engagement and support throughout the weight-loss journey.

    This focus on holistic approaches in the US Gastric Bypass Market ensures that patients receive tailored care, improving long-term success rates and overall satisfaction with surgical outcomes.

    Market Segment Insights

    Gastric Bypass Market Type Insights

    The US Gastric Bypass Market, categorized by Type, showcases significant segments that contribute to the overall landscape of bariatric surgery. Among these, Endoscopic Sleeve Gastroplasty and Intragastric Balloon have emerged as pivotal procedures.

    Endoscopic Sleeve Gastroplasty, a minimally invasive technique, has gained traction owing to its effectiveness and lower complication rates, appealing to patients seeking an alternative to traditional surgical methods. This procedure essentially reshapes the stomach using endoscopic suturing without the need for surgical incisions, thus minimizing recovery time and allowing patients to return to daily activities faster.

    Meanwhile, the Intragastric Balloon procedure provides a temporary aid for weight loss by placing a soft balloon in the stomach, creating a feeling of fullness, which supports patients in achieving their weight loss goals without permanent alterations to their anatomy.

    These segments collectively contribute to the burgeoning interest in weight loss solutions across the US, echoing the increasing prevalence of obesity within the population. According to recent statistics, nearly 42% of US adults are classified as obese, amplifying the demand for effective weight management solutions, including these procedural types.

    The growth drivers for these segments also align with rising healthcare awareness and a greater focus on preventing obesity-related complications, such as diabetes and hypertension. Furthermore, government initiatives to promote healthy living and weight management among citizens continue to bolster the relevance of these interventions.

    Gastric Bypass Market Indication Insights

    The US Gastric Bypass Market, focusing on the Indication segment, is shaped by the rising prevalence of various health conditions such as Gastroesophageal Reflux Disease, Heart Disease, and Type 2 Diabetes. Gastric bypass surgery is often performed on patients suffering from these serious health issues as an effective solution for weight management and improving overall health outcomes.

    For instance, Gastroesophageal Reflux Disease, characterized by persistent acid reflux, affects millions of Americans, and studies suggest that bariatric surgery significantly alleviates symptoms in such patients, offering a substantial quality-of-life improvement.

    Heart Disease remains a leading cause of mortality, and weight loss via gastric bypass can lead to lower risks of heart issues by reducing associated comorbidities. Type 2 Diabetes affects a significant portion of the American population, with numerous studies indicating that gastric bypass contributes to long-term remission in diabetic patients.

    These health conditions underscore the importance of the Indication segment, making it a key driver of demand in the US Gastric Bypass Market, ultimately enabling patients to achieve better health and reduce the burden on healthcare systems. The ongoing advancements in surgical techniques and the growing awareness of obesity as a major health crisis add to the opportunities for growth within this sector.

    Gastric Bypass Market End User Insights

    The US Gastric Bypass Market segmentation by End User is significant, particularly highlighting the roles of Hospitals and Surgical Centers. Hospitals serve as the primary point for comprehensive patient care, offering advanced medical technologies and specialized personnel for managing complex cases involving gastric bypass procedures.

    Their integration into the healthcare system facilitates a multidisciplinary approach, optimizing patient outcomes and satisfaction. Surgical Centers, on the other hand, focus on efficient delivery of outpatient surgical services. They provide convenience and cost-effectiveness, often leading to quicker recovery times for patients post-operation.

    As both End Users adapt to evolving healthcare demands and technological advancements, factors like rising obesity rates in the US bolster their importance. The flexibility of Surgical Centers allows them to accommodate a growing number of procedures, while Hospitals uphold quality standards and ensure extensive follow-up care.

    Together, they create a synergistic landscape that supports the US Gastric Bypass Market, driven by the need for accessible and effective treatment options for obesity-related health issues. Trends indicate a steady upward trajectory in procedures performed, reflecting the increasing acceptance and demand for gastric bypass surgery in the population.

    Get more detailed insights about US Gastric Bypass Market

    Key Players and Competitive Insights

    The US Gastric Bypass Market is characterized by a dynamic landscape driven by advancements in surgical techniques and emerging technologies aimed at enhancing patient outcomes. This market comprises various stakeholders, including medical device manufacturers, healthcare providers, and surgical centers.

    The competition within this sector is intensifying as players strive to innovate and deliver effective treatments for obesity, which has reached epidemic proportions in the United States. The entry of new technologies and a growing emphasis on minimally invasive procedures are reshaping the market dynamics, with companies investing in research and development to capture a larger market share.

    As a result, the competitive environment is marked by partnerships, collaborations, and strategic alliances aimed at expanding product offerings and increasing accessibility for patients seeking gastric bypass procedures.

    Hologic holds a notable position in the US Gastric Bypass Market, primarily recognized for its advanced medical technology solutions that cater to women's health. With a strong focus on innovative surgical instruments and imaging technologies, Hologic has managed to gain a competitive edge.

    The company’s strengths lie in its robust product portfolio that enhances surgical precision and safety during gastric bypass procedures. Hologic's commitment to clinical research and development allows it to refine its offerings continually, promoting better outcomes for patients. Through strategic engagement with healthcare professionals and institutions, Hologic has bolstered its presence in the US market, thus establishing itself as a trusted brand among surgeons and patients alike.

    Bariatric Solutions is another important player in the US Gastric Bypass Market, specializing in the provision of treatments and services related to obesity management. The company focuses on delivering innovative bariatric equipment and surgical solutions designed to support both healthcare providers and patients throughout the weight loss journey.

    Bariatric Solutions prides itself on its comprehensive service offerings that include not only surgical devices but also patient education and support systems, which are critical for long-term success. The company's strong market presence is reflected in its collaborations with various healthcare institutions, enhancing accessibility to their products.

    Additionally, Bariatric Solutions has pursued strategic mergers and acquisitions, enabling it to expand its portfolio and increase its competitiveness in the US market, positioning itself as a reliable partner in addressing the obesity crisis in the region.

    Key Companies in the US Gastric Bypass Market market include

    Industry Developments

    The US Gastric Bypass Market has seen significant developments recently, with advances in technology and increased patient accessibility driving growth. Companies like Hologic and Medtronic are focusing on innovative surgical instruments and techniques that enhance patient outcomes.

    In June 2023, Johnson and Johnson completed its acquisition of a surgical robotics firm, expanding its expertise in minimally invasive procedures, further pushing the capabilities in this market. In July 2023, Boston Scientific showcased new devices aimed at improving long-term weight loss results, highlighting the competitive landscape.

    Additionally, Acelity has been investing in R&D to improve wound management post-surgery, which directly impacts recovery times and patient satisfaction. Market valuation for the Gastric Bypass sector has increased significantly, with a notable uptick in demand for personalized treatment options.

    In the previous years, particularly in 2021 and 2022, there was notable growth driven by a nationwide increase in obesity rates, pushing more patients toward surgical options. With continual advancements in surgical techniques and equipment, the market is poised for sustained expansion, emphasizing the importance of adaptive strategies by key players like Ethicon, Stryker, and Intuitive Surgical.

    Market Segmentation

    Gastric Bypass Market Type Outlook

    • Endoscopic Sleeve Gastroplasty
    • Intragastric Balloon

    Gastric Bypass Market End User Outlook

    • Hospitals
    • Surgical Centers

    Gastric Bypass Market Indication Outlook

    • Gastroesophageal Reflux Disease
    • Heart Disease
    • Type 2 Diabetes

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 212.34(USD Million)
    MARKET SIZE 2024 250.0(USD Million)
    MARKET SIZE 2035 550.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.431% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Hologic, Bariatric Solutions, Medtronic, Boston Scientific, Acelity, Conmed, Stryker, Cook Medical, Terumo, Hernia Solutions, Zimmer Biomet, Johnson and Johnson, Ethicon, Reach Surgical, Intuitive Surgical
    SEGMENTS COVERED Type, Indication, End User
    KEY MARKET OPPORTUNITIES Increasing obesity rates, Technological advancements in procedures, Rising awareness of surgical options, Enhanced patient financing solutions, Growth in telemedicine consultations
    KEY MARKET DYNAMICS Increasing obesity rates, Rising healthcare costs, Technological advancements in procedures, Growing awareness and acceptance, Regulatory approvals and guidelines
    COUNTRIES COVERED US

    FAQs

    What is the expected market value of the US Gastric Bypass Market in 2024?

    The US Gastric Bypass Market is expected to be valued at 250.0 USD Million in 2024.

    What will be the market value of the US Gastric Bypass Market by 2035?

    By 2035, the US Gastric Bypass Market is projected to reach a value of 550.0 USD Million.

    What is the expected CAGR of the US Gastric Bypass Market between 2025 and 2035?

    The expected CAGR for the US Gastric Bypass Market from 2025 to 2035 is 7.431%.

    Which segment is expected to dominate the US Gastric Bypass Market?

    The Endoscopic Sleeve Gastroplasty segment is anticipated to dominate the market.

    What is the projected market value for Endoscopic Sleeve Gastroplasty in 2024?

    The market value for Endoscopic Sleeve Gastroplasty is expected to be 100.0 USD Million in 2024.

    How much is the Intragastric Balloon segment expected to be valued in 2035?

    The Intragastric Balloon segment is expected to be valued at 325.0 USD Million in 2035.

    What are some major players in the US Gastric Bypass Market?

    Major players in the US Gastric Bypass Market include Hologic, Medtronic, and Johnson & Johnson.

    What market growth opportunities are anticipated in the Gastric Bypass Market?

    Growing awareness of obesity treatment and technological advancements present significant market growth opportunities.

    What challenges could affect the US Gastric Bypass Market in the coming years?

    Regulatory challenges and the high cost of procedures could affect market growth.

    How is the overall growth trend expected for the US Gastric Bypass Market by 2035?

    The overall growth trend indicates a positive trajectory towards 550.0 USD Million by 2035, driven by increasing demand.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials